<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jagt VL</submitter><funding>Universitair Medisch Centrum Utrecht</funding><pagination>e0265050</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8912207</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(3)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>The ankle brachial index (ABI) can be used to diagnose peripheral arterial disease (PAD). The clinical relevance of the ABI, especially in patients with known clinically manifest cardiovascular disease (CVD), is unknown. The authors set out to investigate the relationship between a screen-detected ABI and the risk for future cardiovascular morbidity and mortality in patients with clinically manifest CVD.&lt;h4>Design, materials and methods&lt;/h4>Patients with clinically manifest CVD were selected from the UCC-SMART cohort (n = 8360) and divided into four groups: normal ABI (0.91-1.39), screen-detected low ABI ≤ 0.9, screen-detected high ABI ≥ 1.4, and patients with known PAD irrespective of their ABI. Adjusted Cox Proportional Hazard Ratios (HRs) for Major Adverse Cardiovascu</pubmed_abstract><journal>PloS one</journal><pubmed_title>Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease.</pubmed_title><pmcid>PMC8912207</pmcid><funding_grant_id>-</funding_grant_id><pubmed_authors>Jagt VL</pubmed_authors><pubmed_authors>Hazenberg CEVB</pubmed_authors><pubmed_authors>Kapelle J</pubmed_authors><pubmed_authors>UCC-SMART Study Group</pubmed_authors><pubmed_authors>Westerink J</pubmed_authors><pubmed_authors>Visseren FLJ</pubmed_authors><pubmed_authors>Cramer MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease.</name><description>&lt;h4>Objectives&lt;/h4>The ankle brachial index (ABI) can be used to diagnose peripheral arterial disease (PAD). The clinical relevance of the ABI, especially in patients with known clinically manifest cardiovascular disease (CVD), is unknown. The authors set out to investigate the relationship between a screen-detected ABI and the risk for future cardiovascular morbidity and mortality in patients with clinically manifest CVD.&lt;h4>Design, materials and methods&lt;/h4>Patients with clinically manifest CVD were selected from the UCC-SMART cohort (n = 8360) and divided into four groups: normal ABI (0.91-1.39), screen-detected low ABI ≤ 0.9, screen-detected high ABI ≥ 1.4, and patients with known PAD irrespective of their ABI. Adjusted Cox Proportional Hazard Ratios (HRs) for Major Adverse Cardiovascu</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-29T11:02:46.024Z</modification><creation>2025-04-06T19:47:26.201Z</creation></dates><accession>S-EPMC8912207</accession><cross_references><pubmed>35271641</pubmed><doi>10.1371/journal.pone.0265050</doi></cross_references></HashMap>